Clinical Trial Update: Wellbutrin XL, Major Depressive Disorder and Breast Cancer [Phase 4]

View source ↗

Summary

A Phase 4 clinical trial update reports the completion of a study evaluating Wellbutrin XL (bupropion) for major depressive disorder in patients with breast can…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Breast Cancer
• Major Depressive Disorder

Drugs mentioned

• WELLBUTRIN XL (Bupropion hydrochloride)

Snippet

Sponsor: Thomas Jefferson University | Conditions: Breast Cancer, Major Depressive Disorder | Phase 4 | Status: COMPLETED